Evidence map›Paper›PMID 42404893›Full record

ReviewFrontiers in immunology2026

Neuro-immune interactions in cancer: mechanisms and therapeutic prospects.

Jingting Liu, Chun Zhang, Chong Zhang, Jianying Pei, Yan Li

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jingting LiuClinical Laboratory Center, Gansu Provincial Maternity and Child-Care Hospital, Lanzhou, China.
Chun ZhangClinical Laboratory, Lanzhou University of Technology Hospital, Lanzhou, China.
Chong ZhangClinical Laboratory Center, Gansu Provincial Maternity and Child-Care Hospital, Lanzhou, China.
Jianying PeiClinical Laboratory Center, Gansu Provincial Maternity and Child-Care Hospital, Lanzhou, China.
Yan LiDepartment of Biochemistry and Molecular Biology, Medical College of Northwest Minzu University, Lanzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The interplay between the nervous and immune systems has attracted growing scientific attention due to its implications for tumor progression, immune regulation, and potential therapeutic strategies. Although their primary concentration is on inflammation and homeostasis, this basic information emphasizes the crucial role that neuro-immune interaction plays in disease states, including cancer. Neuro-immune interactions are complex and multifaceted, playing significant effects on the pathophysiology of cancer. These interactions involve both peripheral and central neural pathways, modulating immune cell activity within the tumor microenvironment, and offering promising avenues for innovative therapeutic interventions. This review synthesizes recent advancements in understanding the molecular mechanisms, regulatory pathways, and translational applications of the neuro-immune axis in cancer. We explore the intricate roles of neurotransmitters, cytokines, and neurotrophic factors in mediating this crosstalk, examining how the peripheral, central, and enteric nervous systems regulate tumor immunity. Furthermore, we explore emerging therapeutic strategies that target neural inputs, combine neuroimmune modulation with immunotherapy, and consider the impact of epigenetic regulation on the neuroimmune microenvironment. By synthesizing recent advances, this review aims to provide a comprehensive understanding of this intricate field, identify current challenges, and delineate future research directions to harness neuro-immune modulation for offering promising avenues for innovative therapeutic interventions.

Indexed as

NeoplasmsNeuroimmunomodulationAnimalsCytokinesHumansImmunotherapyTumor MicroenvironmentCytokinescancerimmune systemsnervous systemneuro-immunitytumor microenvironment

Identifiers

PMID42404893
PMCPMC13330716

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.